ID ADCL4_HUMAN Reviewed; 407 AA. AC Q5VUY2; DT 12-DEC-2006, integrated into UniProtKB/Swiss-Prot. DT 07-DEC-2004, sequence version 1. DT 27-MAR-2024, entry version 132. DE RecName: Full=Arylacetamide deacetylase-like 4; DE EC=3.1.1.-; GN Name=AADACL4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II CC membrane protein {ECO:0000305}. CC -!- SIMILARITY: Belongs to the 'GDXG' lipolytic enzyme family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL513016; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS30590.1; -. DR RefSeq; NP_001013652.1; NM_001013630.1. DR AlphaFoldDB; Q5VUY2; -. DR SMR; Q5VUY2; -. DR IntAct; Q5VUY2; 1. DR STRING; 9606.ENSP00000365395; -. DR ESTHER; human-AADACL4; Arylacetamide_deacetylase. DR GlyCosmos; Q5VUY2; 2 sites, No reported glycans. DR GlyGen; Q5VUY2; 2 sites. DR iPTMnet; Q5VUY2; -. DR PhosphoSitePlus; Q5VUY2; -. DR BioMuta; AADACL4; -. DR DMDM; 74747169; -. DR PaxDb; 9606-ENSP00000365395; -. DR PeptideAtlas; Q5VUY2; -. DR Antibodypedia; 46608; 103 antibodies from 19 providers. DR DNASU; 343066; -. DR Ensembl; ENST00000376221.2; ENSP00000365395.1; ENSG00000204518.3. DR GeneID; 343066; -. DR KEGG; hsa:343066; -. DR MANE-Select; ENST00000376221.2; ENSP00000365395.1; NM_001013630.2; NP_001013652.1. DR UCSC; uc001auf.3; human. DR AGR; HGNC:32038; -. DR CTD; 343066; -. DR GeneCards; AADACL4; -. DR HGNC; HGNC:32038; AADACL4. DR HPA; ENSG00000204518; Tissue enhanced (choroid). DR neXtProt; NX_Q5VUY2; -. DR OpenTargets; ENSG00000204518; -. DR PharmGKB; PA145147537; -. DR VEuPathDB; HostDB:ENSG00000204518; -. DR eggNOG; KOG1515; Eukaryota. DR GeneTree; ENSGT00940000157630; -. DR HOGENOM; CLU_012494_12_2_1; -. DR InParanoid; Q5VUY2; -. DR OMA; CHLQEGF; -. DR OrthoDB; 1144477at2759; -. DR PhylomeDB; Q5VUY2; -. DR TreeFam; TF314978; -. DR PathwayCommons; Q5VUY2; -. DR SignaLink; Q5VUY2; -. DR BioGRID-ORCS; 343066; 7 hits in 1138 CRISPR screens. DR GeneWiki; AADACL4_(gene); -. DR GenomeRNAi; 343066; -. DR Pharos; Q5VUY2; Tdark. DR PRO; PR:Q5VUY2; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q5VUY2; Protein. DR Bgee; ENSG00000204518; Expressed in omental fat pad and 34 other cell types or tissues. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0052689; F:carboxylic ester hydrolase activity; IEA:InterPro. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR013094; AB_hydrolase_3. DR InterPro; IPR017157; Arylacetamide_deacetylase. DR PANTHER; PTHR48081; AB HYDROLASE SUPERFAMILY PROTEIN C4A8.06C; 1. DR PANTHER; PTHR48081:SF32; ALPHA_BETA HYDROLASE FOLD-3 DOMAIN-CONTAINING PROTEIN; 1. DR Pfam; PF07859; Abhydrolase_3; 2. DR PIRSF; PIRSF037251; Arylacetamide_deacetylase; 1. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. PE 3: Inferred from homology; KW Glycoprotein; Hydrolase; Membrane; Reference proteome; Signal-anchor; KW Transmembrane; Transmembrane helix. FT CHAIN 1..407 FT /note="Arylacetamide deacetylase-like 4" FT /id="PRO_0000265937" FT TOPO_DOM 1..4 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 5..25 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 26..407 FT /note="Lumenal" FT /evidence="ECO:0000255" FT MOTIF 119..121 FT /note="Involved in the stabilization of the negatively FT charged intermediate by the formation of the oxyanion hole" FT /evidence="ECO:0000250|UniProtKB:Q5NUF3" FT ACT_SITE 193 FT /evidence="ECO:0000250|UniProtKB:Q8BLF1" FT ACT_SITE 347 FT /evidence="ECO:0000250|UniProtKB:Q8BLF1" FT ACT_SITE 377 FT /evidence="ECO:0000250|UniProtKB:Q8BLF1" FT CARBOHYD 168 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 269 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" SQ SEQUENCE 407 AA; 46082 MW; CE95EEE9A2C49970 CRC64; MAVPWLVLLL ALPIFFLGVF VWAVFEHFLT TDIPATLQHP AKLRFLHCIF LYLVTLGNIF EKLGICSMPK FIRFLHDSVR IKKDPELVVT DLRFGTIPVR LFQPKAASSR PRRGIIFYHG GATVFGSLDC YHGLCNYLAR ETESVLLMIG YRKLPDHHSP ALFQDCMNAS IHFLKALETY GVDPSRVVVC GESVGGAAVA AITQALVGRS DLPRIRAQVL IYPVVQAFCL QLPSFQQNQN VPLLSRKFMV TSLCNYLAID LSWRDAILNG TCVPPDVWRK YEKWLSPDNI PKKFKNRGYQ PWSPGPFNEA AYLEAKHMLD VENSPLIADD EVIAQLPEAF LVSCENDILR DDSLLYKKRL EDQGVRVTWY HLYDGFHGSI IFFDKKALSF PCSLKIVNAV VSYIKGI //